CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,397
- in 5 filings
Net −$296,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Seshadri Vishwas −$101K Chief Executive Officer sold 2% of stake
- Alvino Mark −$88K Director sold 19% of stake
- Vazzano Joseph Walter −$47K Chief Financial Officer sold 2% of stake
- O'Malley Brendan M. −$35K SVP, Chief Legal Officer sold 2% of stake
- Vasanthavada Madhav −$25K Chief Commercial Officer sold 2% of stake
Reading 57 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-21 | Alvino Mark Director | Grant or award · Stock Option (right to buy) | +19,827 | 19,827 | ||
| 2019-05-21 | Buono Stefano Director | Grant or award · Stock Option (right to buy) | +19,827 | 19,827 | ||
| 2019-05-21 | Howell Stephen B. Director | Grant or award · Stock Option (right to buy) | +19,827 | 19,827 | ||
| 2019-05-21 | Wider Todd Director | Grant or award · Stock Option (right to buy) | +19,827 | 19,827 | ||
| 2019-05-21 | Van Duyne Richard B Director | Grant or award · Stock Option (right to buy) | +19,827 | 19,827 | ||
| 2019-04-11 | Buono Stefano Director | Purchase | +49,020 | $7.91 | $388K | 70,000 |
| 2019-04-10 | Buono Stefano Director | Purchase | +20,980 | $7.54 | $158K | 20,980 |
| 2019-04-09 | Rouhandeh Steven H Executive Chairman | Grant or award · Employee Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2019-04-09 | Miller Timothy J See Remarks | Grant or award · Employee Stock Option (right to buy) | +72,000 | 72,000 | ||
| 2019-04-09 | CARR EDWARD Chief Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2019-04-09 | Siffert Joao MD Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2019-04-09 | Silverstein Christine Berni Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2019-04-08 | Van Duyne Richard B Director | Purchase | +6,000 | $7.71 | $46K | 6,000 |
| 2019-04-08 | Howell Stephen B. Director | Purchase | +4,000 | $7.77 | $31K | 79,494 |
| 2019-02-11 | Siffert Joao MD Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +110,000 | 110,000 | ||
| 2019-01-31 | Siffert Joao MD Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2019-01-07 | Silverstein Christine Berni Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2018-11-19 | CARR EDWARD Chief Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2018-05-22 | Buono Stefano Director | Grant or award · Stock option (right to buy) | +30,000 | 30,000 | ||
| 2018-05-22 | Van Duyne Richard B Director | Grant or award · Stock option (right to buy) | +30,000 | 30,000 |
Page 19 of 23 · 443 trades